Home JeNaCell

JeNaCell

acquired
Series A
Biological Materials Developer

Basic Information

JeNaCell GmbH Develops the Most Innovative Biomaterials for Medical Device TechnologyIn 2017, JeNaCell GmbH launched its first product, Epicite, a medical wound dressing based on biotechnologically derived cellulose for the treatment of chronic wounds, surgical wounds, and burns. It is a skin-friendly and soft biomaterial that provides a healing-promoting microclimate for wounds and can be removed painlessly. Other technologies developed by JeNaCell include soft tissue implants, transdermal drug delivery systems, and dermatological applications.
JeNaCell GmbH
Germany
less than 15 people
January 01, 2012
info@jenacell.de